The impact of HIV and AIDS on Africa's economic development

doi:10.1136/bmj.324.7331.232

BMJ 2002;324:232-234 ( 26 January )

Education and debate

The impact of HIV and AIDS on Africa's economic development

Simon Dixon, lecturer in health economics ^a, Scott McDonald, senior lecturer ^b, Jennifer Roberts, senior lecturer in health economics ^a.

^a School of Health and Related Research, University of Sheffield, Sheffield S1 4DA, ^b Department of Economics, University of Sheffield

Correspondence to: S Dixon S.Dixon@shef.ac.uk

The first 150 words of the full text of this article appear below.

The macroeconomic effects of HIV/AIDS in Africa are substantial, and policies for dealing with them may be controversial $---$ oneis whether expensive antiretroviral drugs should be targeted ateconomically productive groups of people. The authors review theevidence and consider how economic theory can contribute to ourresponse to the pandemic

Three million people died from AIDS in 2001, making it the world's fourth biggest cause of death, after heart disease, stroke,and acute lower respiratory infection.¹ Over 70% of the world's40 million people living with HIV/AIDS are in Africa (table 1).Besides the human cost, HIV/AIDS is having profound effects onAfrica's economic development and hence its ability to cope withthe pandemic. While the impact of HIV/AIDS on people has beenwell documented, it has been much more difficult to observe thepandemic's effects on the African economy as a whole or to assesshow it might affect . . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati What's this?

Relevant Article

Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries: Daniel R Hogan, Rob Baltussen, Chika Hayashi, Jeremy A Lauer, and Joshua A Salomon
BMJ 2005 331: 1431-1437. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

Hogan, D. R, Baltussen, R., Hayashi, C., Lauer, J. A, Salomon, J. A (2005). Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ 331: 1431-1437 [Abstract] [Full text]